09637

Ms. Yun Wang is Executive Director since October 2025 and Chief of Staff since June 2018 at Alebund Pharmaceuticals (Jiangsu) Limited. She serves as Director at Alebund Pharmaceuticals (Jiangsu) Limited since April 18, 2024. Ms. Wang also serves as a director of Alebund Shanghai. Ms. Wang has experience in human resources and corporate operations. From March 2003 to September 2006, she worked as a human resources analyst at Intel (China) Co., Ltd., an indirect subsidiary of Intel Corporation, a company listed on the Nasdaq Global Select Market From September 2006 to August 2008, she served as a compensation and benefits manager at Starbucks Enterprise Management (China) Co., Ltd. a wholly-owned subsidiary of Starbucks Corporation, a company listed on the Nasdaq Global Select Market (stock code: SBUX.Nasdaq). From August 2008 to March 2010, she worked at Deutsche Bank (China) Co., Ltd., Shanghai Branch, a subsidiary of Deutsche Bank AG which is a financial institution listed on the Frankfurt Stock Exchange (stock code: DBK.DE) and the New York Stock Exchange), with her last position being an associate of HR operations. From August 2010 to February 2015, she was a senior compensation and benefits manager at Shanghai Roche Pharmaceuticals Co., Ltd., a subsidiary of Roche Holding AG, a pharmaceutical company listed on the SIX Swiss Exchange (stock code: ROG.SIX) and the OTCQX International Premier market (stock code: RHHBY.OTCQX). From February 2015 to August 2018, she continued to serve at Shanghai Roche Pharmaceuticals Co., Ltd. as a senior HR business partner of global R&D. Ms. Wang obtained her bachelor’s degree in accounting from the University of Shanghai for Science and Technology in July 2002 and her postgraduate diploma in integrated and practicing management from the University of Hong Kong in December 2021.